EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions

Meruert Sarsenova iD, Artjom Stepanjuk, Merli Saare, Sergo Kasvandik, Pille Soplepmann, Iveta Mikeltadze, Martin Götte iD, Andres Salumets, Maire Peters

Genes · 2024

DOI: 10.3390/genes15081086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Meruert Sarsenova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, 50406 Tartu, Estonia. Hauptthemen laut MEDLINE: Endometriosis, Endometrium, Menstrual Cycle, Up-Regulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Estonian Research Council, European Union's Horizon 2020 research and innovation MATER program, Horizon Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a chronic hormone-dependent disease characterized by the spread of endometrial cells outside the uterus, which form endometriotic lesions and disrupt the functions of the affected organs. The etiopathogenesis of endometriosis is still unclear, and thus it is important to examine the genes that may contribute to the establishment of endometriotic lesions. The aim of this study was to investigate the expression of new potential candidate gene latexin (LXN), an inhibitor of carboxypeptidases, in endometrium and endometriotic lesions to elucidate its possible role in endometriosis development. LXN expression in tissues was assessed using quantitative reverse transcription PCR (qRT–PCR) analysis and immunohistochemical staining (IHC). The functions of LXN were examined using Transwell and MTT assays. qRT–PCR analysis revealed that LXN expression in endometrium was menstrual cycle-dependent, being lowest in the early-secretory phase and highest in the late-secretory phase and was significantly upregulated in endometriotic lesions. IHC confirmed LXN expression in endometrial stromal cells, and in vitro assays demonstrated that knockdown of LXN effectively reduced the migratory capacity of endometrial stromal cells while promoting cell viability. In conclusion, our results showed that LXN can be involved in the pathogenesis of endometriosis by regulating the proliferation and migration activity of endometriotic stromal cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisEndometriumMenstrual CycleUp-RegulationHumansFemaleAdultStromal CellsCell MovementCell ProliferationCarboxypeptidases

Stichwörter der Autor:innen

LXNLatexinendometriosisendometriumgene expressionmenstrual cycle

Substanzen

Carboxypeptidases

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, 50406 Tartu, Estonia.
  • Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, and Karolinska University Hospital, 17177 Stockholm, Sweden.
  • Competence Centre on Health Technologies, 50411 Tartu, Estonia.
  • Tartu University Hospital Women's Clinic, 50406 Tartu, Estonia.
  • Department of Surgical and Gynecological Oncology, Tartu University Hospital, 50406 Tartu, Estonia.
  • Department of Gynecology, and Obstetrics, University Hospital of Münster, 48149 Münster, Germany.

ORCID-Profile: Meruert Sarsenova, Martin Götte

Förderung

  • Estonian Research Council
  • European Union's Horizon 2020 research and innovation MATER program
  • Horizon Europe
  • European Commission, and MSCA-RISE-2020
  • European Union’s Horizon 2020 research and innovation MATER program
  • European Commission
  • MSCA-RISE-2020 project TRENDO

Zitieren

APA

Sarsenova, M., Stepanjuk, A., Saare, M., Kasvandik, S., Soplepmann, P., Mikeltadze, I., Götte, M., Salumets, A., & Peters, M. (2024). Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions. Genes. https://doi.org/10.3390/genes15081086

Vancouver

Sarsenova M, Stepanjuk A, Saare M, Kasvandik S, Soplepmann P, Mikeltadze I, et al. Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions. Genes. 2024. doi:10.3390/genes15081086

BibTeX
@article{Sarsenova2024,
  author = {Sarsenova, Meruert and Stepanjuk, Artjom and Saare, Merli and Kasvandik, Sergo and Soplepmann, Pille and Mikeltadze, Iveta and Götte, Martin and Salumets, Andres and Peters, Maire},
  title = {Carboxypeptidase Inhibitor LXN Expression in Endometrial Tissue Is Menstrual Cycle Phase-Dependent and Is Upregulated in Endometriotic Lesions},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15081086}
}
Kostenlos starten →